Get startedLog in
    Picture of Aridis Pharmaceuticals logo

    ARDS — Aridis Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Aridis' Pan-Coronavirus, Inhaled Monoclonal Antibody Cocktail Ar-701 Is Protective In Non-Human Primates

    Picture of Aridis Pharmaceuticals logoAridis Pharmaceuticals
    10/08/2022 13:35
    Aug 10 (Reuters) - Aridis Pharmaceuticals Inc  ARDS.O :
    * ARIDIS' PAN-CORONAVIRUS, INHALED MONOCLONAL ANTIBODY
COCKTAIL
AR-701 IS PROTECTIVE IN NON-HUMAN PRIMATES
    * ARIDIS PHARMACEUTICALS INC - AR-701 IS EFFECTIVE IN VITRO
AGAINST SARS-COV-2 OMICRON SUBVARIANTS, INCLUDING BA.4 AND BA.5

Source text for Eikon:  ID:nPn3kkcrJa 
Further company coverage:  ARDS.O 

 ((reuters.briefs@thomsonreuters.com;))

    Recent news on Aridis Pharmaceuticals

    See all news